Malta - English - Medicines Authority

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - moxifloxacin hydrochloride - solution for infusion - moxifloxacin hydrochloride 400/250 mg/ml - antibacterials for systemic use

Malta - English - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - moxifloxacin - film-coated tablet - moxifloxacin 400 mg - antibacterials for systemic use

Malta - English - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - moxifloxacin - solution for infusion - moxifloxacin 400 mg - antibacterials for systemic use

Singapore - English - HSA (Health Sciences Authority)

duopharma (singapore) pte ltd - moxifloxacin hydrochloride eqv moxifloxacin - tablet, film coated - moxifloxacin hydrochloride eqv moxifloxacin 400mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

alkaloid ad skopje - moxifloxacin (moxifloxacin hydrochloride) - tablets film-coated - 400mg

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - moxifloxacin hcl 436.37 mg eqv moxifloxacin - tablet, film coated - moxifloxacin hcl 436.37 mg eqv moxifloxacin 400 mg

European Union - English - EMA (European Medicines Agency)

pfizer limited - difloxacin - antibacterials for systemic use, antiinfectives for systemic use - turkeys; dogs; cattle; chicken - chickens:for the treatment of chronic respiratory infections caused by sensitive strains of escherichia coli and mycoplasma gallisepticum.turkeys:for the treatment of chronic respiratory infections caused by sensitive strains of escherichia coli and mycoplasma gallisepticum.also for the treatment of infections caused by pasteurella multocida.dogs:for the treatment of acute uncomplicated urinary-tract infections caused by escherichia coli or staphylococcus spp. and superficial pyoderma caused by staphylococcus intermedius.cattle:for the treatment of bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with pasteurella haemolytica, pasteurella multocida and / or mycoplasma spp.

European Union - English - EMA (European Medicines Agency)

bayer animal health gmbh  - pradofloxacin - antibacterials for systemic use, fluoroquinolones - dogs; cats - dogstreatment of:wound infections caused by susceptible strains of the staphylococcus intermedius group (including s. pseudintermedius);superficial and deep pyoderma caused by susceptible strains of the staphylococcus intermedius group (including s. pseudintermedius);acute urinary-tract infections caused by susceptible strains of escherichia coli and the staphylococcus intermedius group (including s. pseudintermedius);as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues caused by susceptible strains of anaerobic organisms, for example porphyromonas spp. and prevotella spp.catstreatment of acute infections of the upper respiratory tract caused by susceptible strains of pasteurella multocida, escherichia coli and the staphylococcus intermedius group (including s. pseudintermedius).

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - danofloxacin - solution for injection - 180 mg/ml - bovine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

schering plough limited - orbifloxacin, micronised - oral suspension - 30 mg/ml - canine - antibacterial